185 related articles for article (PubMed ID: 29264043)
1. Lambert-Eaton myasthenic syndrome with anti-acetylcholine receptor antibody and anterior mediastinal tumor.
Matsumoto H; Ohtomo G; Akahori T; Hashida H
J Gen Fam Med; 2017 Oct; 18(5):282-284. PubMed ID: 29264043
[TBL] [Abstract][Full Text] [Related]
2. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
Sakai W; Nakane S; Matsuo H
Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
[TBL] [Abstract][Full Text] [Related]
3. A case of lambert-eaton myasthenic syndrome with small-cell lung cancer and transient increase in anti-acetylcholine-receptor-binding antibody titer.
Lee JH; Shin HY; Kim SM; Sunwoo IN
J Clin Neurol; 2012 Dec; 8(4):305-7. PubMed ID: 23323140
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia gravis Lambert-Eaton overlap syndrome.
Oh SJ
Muscle Nerve; 2016 Jan; 53(1):20-6. PubMed ID: 26418033
[TBL] [Abstract][Full Text] [Related]
5. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
Schoser B; Eymard B; Datt J; Mantegazza R
J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304
[TBL] [Abstract][Full Text] [Related]
6. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
Kitanosono H; Shiraishi H; Motomura M
Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
[TBL] [Abstract][Full Text] [Related]
7. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
Takamori M
J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of durvalumab plus chemotherapy in small-cell lung cancer with Lambert-Eaton myasthenic syndrome.
Ishibashi N; Tabata T; Nonomura R; Oshima Y; Sasaki T; Mitomo H; Sugawara T; Sagawa M
Respir Med Case Rep; 2024; 47():101974. PubMed ID: 38374927
[TBL] [Abstract][Full Text] [Related]
9. Relapse of both small cell lung cancer and Lambert-Eaton myasthenic syndrome after a 13-year disease-free survival period.
Asano F; Watanabe K; Shinkai M; Tei Y; Mishina K; Tanabe M; Ishii H; Shinoda M; Shimokawaji T; Kudo M; Kaneko T
Chin J Cancer; 2016 Jul; 35(1):63. PubMed ID: 27370896
[TBL] [Abstract][Full Text] [Related]
10. [A case of myasthenia gravis with coexistence of anti-acetylcholine receptor antibodies and anti-P/Q-type VGCC antibodies].
Takeda Y; Noda Y; Seike N; Ishihara H
Rinsho Shinkeigaku; 2024 Apr; 64(4):292-295. PubMed ID: 38508730
[TBL] [Abstract][Full Text] [Related]
11. Lambert-Eaton myasthenic syndrome in a patient with small-cell lung cancer: A case report.
Zhang RR; Han T; Guo F; Liu ZZ; Han YL; Chen WC; Liu YY; Xie XD
Oncol Lett; 2015 Sep; 10(3):1339-1342. PubMed ID: 26622673
[TBL] [Abstract][Full Text] [Related]
12. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
Iwanami M; Odaka M; Nakamura T; Hirata K
Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to synthetic peptides of the alpha1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome.
Takamori M; Iwasa K; Komai K
Neurology; 1997 May; 48(5):1261-5. PubMed ID: 9153453
[TBL] [Abstract][Full Text] [Related]
14. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Motomura M; Lang B; Johnston I; Palace J; Vincent A; Newsom-Davis J
J Neurol Sci; 1997 Mar; 147(1):35-42. PubMed ID: 9094058
[TBL] [Abstract][Full Text] [Related]
15. Atezolizumab-Induced Lambert-Eaton Myasthenic Syndrome in a Patient With Small-Cell Lung Cancer.
Yamazoe M; Hatakeyama T; Furukawa K; Kato K; Horiuchi K
Cureus; 2023 Jan; 15(1):e33557. PubMed ID: 36779131
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of myasthenia gravis and Lambert-Eaton myasthenic syndrome in a small cell lung cancer patient: A case report.
Jia R; Chen J; Ge R; Zheng Q; Chen F; Zhao Z
Medicine (Baltimore); 2018 Jun; 97(23):e10976. PubMed ID: 29879051
[TBL] [Abstract][Full Text] [Related]
17. Durvalumab for Extensive-Stage of Small-Cell Lung Cancer With Lambert-Eaton Myasthenic Syndrome.
Machiyama H; Minami S
J Med Cases; 2023 Feb; 14(2):71-75. PubMed ID: 36896371
[TBL] [Abstract][Full Text] [Related]
18. [Resected thymic hyperplasia with myasthenia gravis and Lambert-Eaton myasthenic syndrome].
Mitomo H; Tabata T; Sugawara T; Miyamoto A; Fujimura S; Murakami K
Kyobu Geka; 2014 Mar; 67(3):194-7. PubMed ID: 24743528
[TBL] [Abstract][Full Text] [Related]
19. Voltage gated calcium channel antibody-related neurological diseases.
Bekircan-Kurt CE; Derle Çiftçi E; Kurne AT; Anlar B
World J Clin Cases; 2015 Mar; 3(3):293-300. PubMed ID: 25789302
[TBL] [Abstract][Full Text] [Related]
20. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]